Cadence Capital Management’s Elevance Health ELV Stock Holding History

Cadence Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,270	Closed	-$901K	–	679
2016 Q4	$901K	Buy	6,270 +254	+4%	+$34K	0.06%	382
2016 Q3	$754K	Buy	6,016 +1,517	+34%	+$196K	0.06%	388
2016 Q2	$591K	Buy	4,499 +36	+0.8%	+$4.93K	0.04%	417
2016 Q1	$620K	Sell	4,463 -543	-11%	-$72.6K	0.04%	424
2015 Q4	$698K	Buy	5,006 +4	+0.1%	+$551	0.05%	405
2015 Q3	$700K	Buy	+5,002	New	+$752K	0.05%	394

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cadence Capital Management's ELV Position: Q1 2017 in Review

Cadence Capital Management sold out of Elevance Health (ELV) in Q1 2017, closing a stake of 6,270 shares — an estimated $901K sold.

Cadence Capital Management first reported a position in ELV in Q3 2015 and held it in 6 quarters. The position peaked at $901K in Q4 2016. 796 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

Cadence Capital Management reported no remaining Elevance Health position as of Q1 2017 after selling out during the quarter.
Cadence Capital Management sold 6,270 Elevance Health shares in Q1 2017, an estimated $901K.
Cadence Capital Management first reported a position in Elevance Health in Q3 2015 and held it in 6 quarters.
Cadence Capital Management's Elevance Health position peaked at $901K in Q4 2016.
796 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on Cadence Capital Management's 13F filing for Q1 2017, filed 11 May 2017.